Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Page will reload when a filter is removed.
Reset Filters
Applied Filters:
Language:
Remove Filter
eng
Page will reload when a filter is removed.
Reset Filters
Show filters (1)
Language:
Remove Filter
eng
EVEROLIMUS PLUS OCTREOTIDE LAR...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
EVEROLIMUS PLUS OCTREOTIDE LAR IN PATIENTS WITH LUNG CARCINOIDS
Bibliographic Details
Main Authors:
Granberg, D
,
Fazio, N
,
Grossman, A
,
Saletan, S
,
Pannnerselvam, A
,
Wolin, E
Format:
Journal article
Published:
2014
Holdings
Description
Similar Items
Staff View
Similar Items
Effect of Everolimus plus Octreotide LAR in Patients With Advanced Lung Neuroendocrine Tumours - Analysis From RADIANT-2
by: Fazio, N, et al.
Published: (2011)
Everolimus plus octreotide long-acting repeatable in patients with advanced lung neuroendocrine tumors: analysis of the phase 3, randomized, placebo-controlled RADIANT-2 study.
by: Fazio, N, et al.
Published: (2013)
Everolimus in combination with octreotide LAR in thymic atypical carcinoid
by: Tadashi Sakane, et al.
Published: (2023-05-01)
Metastatic Recurrence of Typical Pulmonary Carcinoid Accompanied by Carcinoid Syndrome, Successfully Treated with Octreotide LAR
by: Asako Yanagisawa, et al.
Published: (2017-01-01)
90Y-edotreotide for metastatic carcinoid refractory to octreotide.
by: Bushnell, D, et al.
Published: (2010)